Europe Pulmonary Function Testing Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2024 –2031 |
 Размер рынка (базовый год) |
USD 997.65 Million |
 Размер рынка (прогнозируемый год) |
USD 1,522.79 Million |
 CAGR |
% |
| Основные игроки рынка |
Europe Pulmonary Function Testing Market, By Type (Hardware, Services, and Software), Patient Type (Pediatric, Adult, and Geriatric), Application (Obstructive Lung Disease and Restrictive Lung Disease), End User (Hospital, Specialty Clinics, Diagnostics Laboratories, Home Care Settings, and Others) - Industry Trends and Forecast to 2031.
Europe Pulmonary Function Testing Market Analysis and Insights
The pulmonary function testing market is driven by the increasing prevalence of respiratory diseases, technological advancements, and growing demand for personalized medicine. Key trends in the market include the increasing adoption of point-of-care PFT devices, growing demand for wireless and portable PFT devices, and rising focus on personalized medicine and precision medicine. However, the market also faces challenges such as limited accessibility of PFT devices in some regions, high cost of PFT devices and consumables, complexity of PFT interpretation and analysis, and limited awareness about PFT among healthcare providers and patients.
Data Bridge Market Research analyzes that the Europe pulmonary function testing market is expected to reach USD 1,522.79 million by 2031 from USD 997.65 million in 2023, growing at a CAGR of 5.5% in the forecast period of 2024 to 2031.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016–2021) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Type (Hardware, Services, and Software), Patient Type (Pediatric, Adult, and Geriatric), Application (Obstructive Lung Disease and Restrictive Lung Disease), End User (Hospital, Specialty Clinics, Diagnostics Laboratories, Home Care Settings, and Others) |
|
Countries Covered |
Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands, Sweden, Denmark, Norway, Finland, Poland, and rest of Europe |
|
Market Players Covered |
VYAIRE MEDICAL, INC., Teleflex Incorporated, CAIRE, Inc., COSMED srl, Schiller AG, Ganshorn Medizin Electronic GmbH, ndd Medical Technologies, KoKo PFT, GERATHERM MEDICAL AG, ECO MEDICS, SIBEL, S.A.U., Clarity Medical, Data Sciences International, MEC, Scireq, MEDLINE, Recorders and Medicare Systems, VITALOGRAPH, medical equipment europe GMBH, CHEST M.I., Inc., and CONTEC MEDICAL SYSTEMS CO., LTD among others |
Market Definition
Pulmonary Function Testing (PFT) is a comprehensive assessment of lung function, used to diagnose and monitor respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and chronic bronchitis. The market definition of PFT includes a range of tests, including Forced Vital Capacity (FVC), Forced Expiratory Volume (FEV1), FEV1/FVC Ratio, Maximal Voluntary Ventilation (MVV), and Diffusion Capacity (DLCO). PFT is typically performed using a spirometer, a device that measures the volume and flow of air inhaled and exhaled by the patient.
Europe Pulmonary Function Testing Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Prevalence of Respiratory Disease
The increasing prevalence of respiratory diseases is a significant driver for the global pulmonary function testing market. Conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma are becoming more common due to factors like aging populations, environmental pollutants, and lifestyle changes. As these diseases grow in prevalence, there is a heightened demand for accurate and reliable diagnostic tools to manage and monitor these conditions. Pulmonary function tests are crucial for diagnosing respiratory diseases, assessing their severity, and tracking disease progression. This increased need for regular and precise testing drives the market, as healthcare providers and patients seek advanced PFT technologies to improve respiratory health outcomes and provide effective management strategies.
- Early Detection of Respiratory Diseases
The increasing respiratory disorders of early detection is a key driver for the global Pulmonary Function Testing (PFT) market. The surge in respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic fibrosis fuels the demand for pulmonary function testing. The pulmonary function tests play a crucial role in enabling early detection and efficient management of respiratory conditions, thereby improving patient outcomes and quality of life through timely intervention and treatment.
Opportunity
- Rapid Technological Advancements
The development of innovative PFT devices, particularly those integrated with AI, enhances diagnostic accuracy and efficiency, offering more reliable results in identifying pulmonary diseases. Comprehensive testing systems are becoming increasingly user-friendly and portable, making them accessible to a broader range of healthcare settings. The integration with digital health technologies, such as AI and telemedicine, allows for advanced diagnostic accuracy and predictive analytics, as well as remote monitoring through connected PFT devices, expanding the reach and impact of these tools. Advanced sensor technologies, including high-sensitivity and wearable sensors, provide continuous monitoring and real-time data collection, enabling more precise and timely interventions.
Challenges/Restraints
- High Cost of Testing Equipment
The high cost of pulmonary function testing equipment hampers market growth by restricting access for smaller healthcare facilities and hindering penetration in certain regions. The substantial investment required for purchasing and maintaining sophisticated PFT devices poses financial challenges for healthcare facilities, particularly in developing regions. This economic barrier restricts the widespread adoption and use of PFT technologies, affecting overall market growth and accessibility. Addressing these cost challenges is essential for enhancing the reach and impact of pulmonary function testing worldwide.
- Lack of Standardization and Variability in Test Results
A notable lack of uniform standards leads to variability in device specifications and test protocols, which can hinder the consistency and comparability of test results across different equipment. This variability complicates efforts to integrate PFT devices with Electronic Health Record (EHR) systems, making seamless data exchange and comprehensive patient records more difficult to achieve. Without standardized protocols, ensuring that data from various PFT devices can be accurately and efficiently integrated into EHR systems remains a complex task.
Recent Developmevnts
- In April 2024, Clario's acquisition of ArtiQ enhances its Respiratory Solutions portfolio by integrating advanced AI capabilities. This strategic move combines Clario's expertise with ArtiQ’s innovative technology to improve test quality and accelerate data processing in clinical trials. The acquisition, alongside Inofab Health, solidifies Clario's leadership in respiratory care and broadens its AI-driven clinical solutions
- In September 2023, PulmOne has launched the MiniBox+ in China, showcasing it to pulmonologists at the 2023 Annual Congress of the Chinese Thoracic Society (CTS) through our distributor HTDK. The introduction was met with great enthusiasm from attendees. Check out the exciting video highlights from the event
- In May 2023, Geratherm Medical AG, was honored as a "hidden champion" by the State Development Corporation of Thuringia (LEG). The recognition highlights the company's significant role in medical technology and its global market presence. Board member Christian Frick expressed gratitude for the accolade, noting the company's innovation in medical diagnostics, lung function measurement, stroke prevention, and incubator systems, which positions it well for future growth
- In May 2023, Vitalograph, a leader in respiratory diagnostics, has expanded its portfolio with the introduction of the Vitalograph tremoflo C-100 Oscillometer at the ATS International Conference. Developed in partnership with Thorasys, this innovative device detects small airway impairment through simple tidal breathing, enhancing the diagnosis of asthma and COPD. The tremoflo C-100 integrates with the Vitalograph Spirotrac platform, offering a comprehensive view of respiratory health and supporting accurate, portable testing in various settings
- In April 2023, Ingmar Medical introduced RespiSim Software Version 4.3 a key advancement, including improved scenario import/export, reduced simulation lag, and enhanced platform stability. These updates significantly elevate usability and performance, making it a vital tool for respiratory therapy education and training
- In September 2022, IngMar Medical launches RespiSim eLearning, a subscription-based platform providing affordable, realistic ventilation training. Featuring a Virtual Ventilator and a suite of Cleveland Clinic courses, this new offering supports hybrid and remote education, fostering a community of educators dedicated to enhancing patient outcomes
Europe Pulmonary Function Testing Market Scope
The Europe pulmonary function testing market is segmented into four notable segments based on type, patient type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Type
- Hardware
- Software
- Services
On the basis of service, the Europe pulmonary function testing market is segmented into hardware, software, and services.
Patient Type
- Adult
- Geriatric
- Pediatric
On the basis of patient type, the Europe pulmonary function testing market is segmented into adult, geriatric, and pediatric.
Application
- Obstructive Lung Disease
- Restrictive Lung Disease
On the basis of application, the Europe pulmonary function testing market is segmented into obstructive lung disease and restrictive lung disease.
End User
- Hospital
- Specialty Clinics
- Diagnostics Laboratories
- Home Care Settings
- Others
On the basis of end user, the Europe pulmonary function testing market is segmented into hospital, specialty clinics, diagnostics laboratories, home care settings, and others.
Europe Pulmonary Function Testing Market Regional Analysis/Insights
The Europe pulmonary function testing market is segmented into four notable segments based on type, patient type, application, and end user.
The countries covered in this market report are Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands, Sweden, Denmark, Norway, Finland, Poland, and rest of Europe.
Germany is expected to dominate the market in Europe region due to increasing product launches and emergence of home testing devices.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of large services company and their challenges faced due to large or scarce competition from local and domestic players and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Pulmonary Function Testing Market Share Analysis
The Europe pulmonary function testing market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
The major market players operating in the market are VYAIRE MEDICAL, INC., Teleflex Incorporated, CAIRE, Inc., COSMED srl, Schiller AG, Ganshorn Medizin Electronic GmbH, ndd Medical Technologies, KoKo PFT, GERATHERM MEDICAL AG, ECO MEDICS, SIBEL, S.A.U., Clarity Medical, Data Sciences International, MEC, Scireq, MEDLINE, Recorders and Medicare Systems, VITALOGRAPH, medical equipment europe GMBH, CHEST M.I., Inc., and CONTEC MEDICAL SYSTEMS CO., LTD among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE PULMONARY FUNCTION TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES
6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES
6.1.3 GROWING GERIATRIC POPULATION
6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES
6.2 RESTRAINTS
6.2.1 HIGH COST OF TESTING EQUIPMENT
6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES
6.3 OPPORTUNITIES
6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING STRATEGIC INITIATIVES
6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES
6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING
6.4 CHALLENGES
6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS
6.4.2 LACK OF SKILLED PROFESSIONALS
7 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE
7.1 OVERVIEW
7.2 HARDWARE
7.2.1 PFT DEVICES
7.2.2 PFT ACCESSORIES & CONSUMABLES
7.2.2.1 Spirometry
7.2.2.2 Lung Volume in Unit/ Plethysmography Test
7.2.2.3 Gas Exchange Testing
7.2.2.4 Cardiopulmonary Exercise Test (CPET)
7.2.2.5 Pulse Oximetry Test
7.2.2.6 Diffusion Capacity Test
7.2.2.7 Maximal Voluntary Ventilation
7.2.2.8 Oxygen Titration Test
7.2.2.9 Respiratory Muscle Function
7.2.2.10 Bronchial Provocation Test
7.2.2.11 High Altitude Simulation Testing
7.2.3 OTHERS
7.2.3.1 3.2. Direct Tender
7.2.3.2 3.2. Retail Sales
7.2.4 OTHERS
7.3 SOFTWARE
7.4 SERVICES
8 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE
8.1 OVERVIEW
8.2 ADULT
8.2.1 MALE
8.2.2 FEMALE
8.3 GERIATRIC
8.3.1 MALE
8.3.2 FEMALE
8.4 PEDIATRIC
8.4.1 MALE
8.4.2 FEMALE
9 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 OBSTRUCTIVE LUNG DISEASE
9.2.1 ASTHMA
9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
9.2.3 BRONCHIECTASIS
9.2.4 CYSTIC FIBROSIS
9.3 RESTRICTIVE LUNG DISEASE
9.3.1 LUNG CANCER
9.3.2 INTERSTITIAL LUNG DISEASE
9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)
9.3.4 SCOLIOSIS
9.3.5 SARCOIDOSIS
9.3.6 MUSCULAR DYSTROPHY
10 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PUBLIC
10.2.2 PRIVATE
10.3 SPECIALTY CLINICS
10.4 DIAGNOSTICS LABORATORIES
10.5 HOME CARE SETTINGS
10.6 OTHERS
11 EUROPE PULMONARY FUNCTION TESTING MARKET, BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 U.K.
11.1.3 FRANCE
11.1.4 FRANCE
11.1.5 ITALY
11.1.6 TURKEY
11.1.7 RUSSIA
11.1.8 SWITZERLAND
11.1.9 NETHERLANDS
11.1.10 SWEDEN
11.1.11 BELGIUM
11.1.12 DENMARK
11.1.13 NORWAY
11.1.14 FINLAND
11.1.15 POLAND
11.1.16 REST OF EUROPE
12 EUROPE PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 VYAIRE MEDICAL, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 COMPANY SHARE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 TELEFLEX INCORPORATED
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO 258
14.2.5 RECENT DEVELOPMENT 258
14.3 CAIRE INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 COMPANY SHARE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 COSMED SRL
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 SCHILLER AG
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 CHEST M.I., INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 CLARITY MEDICAL
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 CONTEC MEDICAL SYSTEMS CO., LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DATA SCIENCES INTERNATIONAL.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ECO MEDICS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 FUKUDA SANGYO CO., LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 GANSHORN MEDIZIN ELECTRONIC GMBH
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GERATHERM MEDICAL AG
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 INGMAR MEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 INOFAB HEALTH (A CLARIO COMPANY)
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 JK MEDICAL SYSTEMS PVT LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 KOKO, PFT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 MEC
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 MEDICAL EQUIPMENT EUROPE GMBH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MEDLINE
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 MORGAN SCIENTIFIC
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENTS
14.22 NDD MEDICAL TECHNOLOGIES
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PULMONE ADVANCED MEDICAL DEVICES
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 SCIREQ
14.25.1 COMPANY SNAPSHOT
14.25.2 PRODUCT PORTFOLIO
14.25.3 RECENT DEVELOPMENT
14.26 SIBEL, S.A.U
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENT
14.27 VITALOGRAPH
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Список таблиц
TABLE 1 EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 2 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 3 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 6 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 7 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 9 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 11 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 13 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 EUROPE SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 EUROPE SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 20 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 22 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 24 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 25 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 27 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 29 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 30 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 EUROPE SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 EUROPE DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 EUROPE HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 EUROPE OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 EUROPE PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 37 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 40 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 41 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 43 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 44 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 45 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 47 EUROPE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 50 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 51 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 52 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 53 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 54 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 56 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 GERMANY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 61 GERMANY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 GERMANY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 64 GERMANY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 65 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 67 GERMANY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 GERMANY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 70 GERMANY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 71 GERMANY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 72 GERMANY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 73 GERMANY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 GERMANY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 GERMANY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 76 GERMANY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 U.K. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 81 U.K. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 U.K. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 84 U.K. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 87 U.K. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 U.K. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 90 U.K. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 91 U.K. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 92 U.K. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 93 U.K. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 U.K. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 U.K. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 96 U.K. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 FRANCE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 101 FRANCE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 102 FRANCE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 103 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 104 FRANCE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 107 FRANCE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 FRANCE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 110 FRANCE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 111 FRANCE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 112 FRANCE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 113 FRANCE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 FRANCE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 FRANCE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 116 FRANCE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 SPAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 121 SPAIN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 SPAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 124 SPAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 126 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 127 SPAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 SPAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 130 SPAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 131 SPAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 132 SPAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 133 SPAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 SPAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 SPAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 136 SPAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 ITALY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 138 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 139 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 141 ITALY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 ITALY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 144 ITALY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 147 ITALY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 148 ITALY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 150 ITALY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 151 ITALY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 152 ITALY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 153 ITALY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 ITALY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 ITALY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 156 ITALY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 TURKEY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 161 TURKEY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 TURKEY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 164 TURKEY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 167 TURKEY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 TURKEY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 170 TURKEY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 171 TURKEY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 172 TURKEY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 173 TURKEY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 174 TURKEY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 TURKEY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 176 TURKEY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 181 RUSSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 RUSSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 184 RUSSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 187 RUSSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 189 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 190 RUSSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 191 RUSSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 192 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 193 RUSSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 194 RUSSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 196 RUSSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 201 SWITZERLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 SWITZERLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 204 SWITZERLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 205 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 206 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 207 SWITZERLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 209 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 210 SWITZERLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 211 SWITZERLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 212 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 213 SWITZERLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 214 SWITZERLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 SWITZERLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 218 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 221 NETHERLANDS PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 NETHERLANDS MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 223 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 224 NETHERLANDS NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 225 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 226 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 227 NETHERLANDS RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 228 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 229 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 230 NETHERLANDS GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 231 NETHERLANDS PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 232 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 233 NETHERLANDS OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 234 NETHERLANDS RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 235 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 236 NETHERLANDS HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 237 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 238 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 239 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 241 SWEDEN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 242 SWEDEN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 243 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 244 SWEDEN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 245 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 246 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 247 SWEDEN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 248 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 249 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 250 SWEDEN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 251 SWEDEN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 252 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 253 SWEDEN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 254 SWEDEN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 255 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 256 SWEDEN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 257 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 258 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 259 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 260 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 261 BELGIUM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 262 BELGIUM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 263 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 264 BELGIUM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 265 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 266 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 267 BELGIUM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 269 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 270 BELGIUM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 271 BELGIUM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 272 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 273 BELGIUM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 274 BELGIUM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 275 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 276 BELGIUM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 277 DENMARK PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 278 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 279 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 280 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 281 DENMARK PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 DENMARK MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 283 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 284 DENMARK NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 285 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 286 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 287 DENMARK RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 DENMARK PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 289 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 290 DENMARK GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 291 DENMARK PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 292 DENMARK PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 293 DENMARK OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 294 DENMARK RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 295 DENMARK PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 296 DENMARK HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 297 NORWAY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 298 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 299 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 300 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 301 NORWAY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 302 NORWAY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 303 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 304 NORWAY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 305 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 306 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 307 NORWAY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 308 NORWAY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 309 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 310 NORWAY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 311 NORWAY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 312 NORWAY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 313 NORWAY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 314 NORWAY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 315 NORWAY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 316 NORWAY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 317 FINLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 318 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 319 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 320 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 321 FINLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 322 FINLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 323 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 324 FINLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 325 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 326 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 327 FINLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 328 FINLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 329 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 330 FINLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 331 FINLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 332 FINLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 333 FINLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 334 FINLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 335 FINLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 336 FINLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 337 POLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 338 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 339 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 341 POLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 342 POLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 343 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 344 POLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 345 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 346 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 347 POLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 348 POLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 349 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 350 POLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 351 POLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 352 POLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 353 POLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 354 POLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 355 POLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 356 POLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 357 REST OF EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
Список рисунков
FIGURE 1 EUROPE PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 2 EUROPE PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PULMONARY FUNCTION TESTING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 11 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE EUROPE PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031
FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023
FIGURE 18 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 20 EUROPE PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023
FIGURE 22 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 24 EUROPE PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 25 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023
FIGURE 26 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 EUROPE PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 EUROPE PULMONARY FUNCTION TESTING MARKET: BY END USER 2023
FIGURE 30 EUROPE PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 31 EUROPE PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)
FIGURE 32 EUROPE PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE
FIGURE 33 EUROPE PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)
FIGURE 34 EUROPE PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
